# Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results
Canonical URL: https://biopharmsignal.com/news/SUPN/supernus-announces-record-fourth-quarter-and-full-year-2025-financial-results
Ticker: SUPN
Company: Supernus
Source: Supernus
Published: 2026-02-24 21:05 EST
Original Source URL: https://ir.supernus.com
## Summary

Record total revenues of $211.6 million and $719.0 million in the fourth quarter and full year 2025, a 21% and 9% increase compared to same periods last year. Combined revenues of the Company's four growth products increased to $161.3 million and $521.8 million in the fourth quarter and full year

## Article Body
Record total revenues of $211.6 million and $719.0 million in the fourth quarter and full year 2025, a 21% and 9% increase compared to same periods last year. Combined revenues of the Company's four growth products increased to $161.3 million and $521.8 million in the fourth quarter and full year
## Recent Company News
- 2026-07-22 21:05 EST — [Supernus Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 4, 2026](https://biopharmsignal.com/news/SUPN/supernus-pharmaceuticals-to-announce-second-quarter-2026-financial-results-and-h-58b4f63d) — Source: Supernus
- 2026-07-14 12:30 EST — [Supernus Celebrates Five-Year Anniversary of Qelbree® FDA Approval, Continuing to Deliver on Real-World Experience in ADHD](https://biopharmsignal.com/news/SUPN/supernus-celebrates-five-year-anniversary-of-qelbree-fda-approval-continuing-to--ca53fc4f) — Source: Supernus
- 2026-05-27 20:30 EST — [Supernus Pharmaceuticals to Participate in June Investor Conferences](https://biopharmsignal.com/news/SUPN/supernus-pharmaceuticals-to-participate-in-june-investor-conferences) — Source: Supernus
- 2026-05-06 21:00 EST — [Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference](https://biopharmsignal.com/news/SUPN/supernus-pharmaceuticals-to-participate-in-the-bank-of-america-2026-health-care-conference) — Source: Supernus
- 2026-05-05 20:05 EST — [Supernus Announces First Quarter 2026 Financial Results](https://biopharmsignal.com/news/SUPN/supernus-announces-first-quarter-2026-financial-results) — Source: Supernus
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)